Precision Diagnostics for Definitive Clinical Decisions.
PATHOSURE® is a vertically integrated precision diagnostics company providing an end-to-end pathway from specimen collection and laboratory processing to pathology, immunohistochemistry, molecular oncology and clinical reporting.
Accurate Diagnosis. Better Treatment. Healthier Lives.

From specimen to clinical decision.
PATHOSURE® brings complementary diagnostic disciplines together so that the clinical question remains visible throughout the pathway.
Experienced Pathologists
Diagnostic interpretation and reporting supported by experienced pathologists as part of the PATHOSURE® clinical workflow.
Comprehensive. Integrated. Patient-centred.
Explore each diagnostic service in depth, including indications, specimen considerations, workflow, turnaround expectations and referral pathways.
Histopathology
Biopsy and surgical specimen evaluation, tissue processing, H&E microscopy and pathologist reporting.
Explore Histopathology →Cytology
FNA/FNAC, Pap smear and cellular specimen evaluation with correlation and escalation where indicated.
Explore Cytology →Immunohistochemistry
Disease-based IHC panels designed around diagnostic questions and tumour classification.
Explore IHC Panels →Molecular Oncology
A precision oncology pathway linking morphology, biomarkers and molecular testing.
Explore Molecular Oncology →Oncology Centre
Patient education covering cancer diagnosis, treatment modalities, medicines, side effects, nutrition and survivorship.
Explore Oncology →Digital Diagnostics
Website, PATHOSURE® App and eNexus Pro™ Cloud LIMS connected through secure APIs.
Explore Technology →
Precision Diagnostics for Definitive Clinical Decisions